Benevolo, G., Elli, E. M., Guglielmelli, P., Ricco, A., & Maffioli, M. (2020). Thrombocytopenia in patients with myelofibrosis: Management options in the era of JAK inhibitor therapy. Leukemia & lymphoma, 61(7), 1535-1547. https://doi.org/10.1080/10428194.2020.1728752
Chicago Style (17th ed.) CitationBenevolo, Giulia, Elena M. Elli, Paola Guglielmelli, Alessandra Ricco, and Margherita Maffioli. "Thrombocytopenia in Patients with Myelofibrosis: Management Options in the Era of JAK Inhibitor Therapy." Leukemia & Lymphoma 61, no. 7 (2020): 1535-1547. https://doi.org/10.1080/10428194.2020.1728752.
MLA (9th ed.) CitationBenevolo, Giulia, et al. "Thrombocytopenia in Patients with Myelofibrosis: Management Options in the Era of JAK Inhibitor Therapy." Leukemia & Lymphoma, vol. 61, no. 7, 2020, pp. 1535-1547, https://doi.org/10.1080/10428194.2020.1728752.